Fund Holdings — TAKEDA PHARMACEUTICAL CO LTD

Total Portfolio Value
$16.19M
Total Bought
$0
Total Sold
$0
Net Transaction
$0
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
American Well Corporation(AMWL)77,73377,73305646133.78%+49
Standard Biotools, Inc.(LAB)16,51516,515029180.11%-11
Rani Therapeutics Holdings, Inc.(RANI)203,190203,19002782561.58%-22
Turnstone Biologics895,824895,82404483672.27%-81
Lyell Immunopharma, Inc.(LYEL)823,317823,31705274432.74%-84
Shattuck Labs, Inc.(STTK)515,619515,61906244903.02%-134
Third Harmonic Bio, Inc.36,83536,83503791280.79%-251
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)(XLO)1,475,1211,475,12101,4161,0686.59%-348
Equillium, Inc.(EQ)1,824,9771,824,97701,3697124.40%-657
HilleVax, Inc.6,724,0006,724,000013,9199,75060.21%-4,168
Ovid Therapeutics, Inc.(OVID)7,531,9967,531,99607,0122,35014.51%-4,662
Page 1 of 1
TAKEDA PHARMACEUTICAL CO LTD — 13F Holdings — Q1 2025 | TickerTrail